Is adenosine a second metabolic substrate for human red blood cells?
Adenosine is present in the micromolar range in human plasma. In this study, metabolism of adenosine, which was maintained between 0.62 +/- 0.03 and 2.92 +/- 0.43 microM by means of a continuous infusion using a Harvard infusion pump, was investigated in human red blood cells. It was found that lactate production increases linearly as the adenosine concentration was raised. Cells infused with an average adenosine concentration of 2 microM produced lactate comparable to that produced by 5 mM glucose. The extent to which ATP concentration is maintained by adenosine also depends on its concentration. After a 4 h infusion with an average adenosine concentration of 0.7 microM, ATP content amounts to 75% of the glucose control. Raising the adenosine infusion concentration to 1.5 microM results in a full maintenance of ATP levels and at concentrations higher than 1.5 microM, adenosine produces a net synthesis of ATP. A net synthesis of ATP also occurs with adenosine concentration below 1.5 microM, if supplemented with glucose. In contrast, inosine infusion provides only a partial support of ATP and fails to produce a net synthesis of ATP in the presence of glucose. In addition, the presence of purine nucleoside and glucose together influence the metabolism of each other, depending on inorganic phosphate content (Pi). At a Pi concentration of 1 mM, the glucose consumption rate is reduced by approx. 25% by purine nucleoside infusion and vice versa. In sharp contrast, glucose consumption at 16 mM Pi is potentiated by adenosine. These findings suggest that plasma adenosine contributes significantly to human red cell energetics, even though it is present at a concentration several orders of magnitude lower than glucose.
Kim
H D
HD
Department of Pharmacology, University of Missouri-Columbia 65212.
D000241:Adenosine / Q000097:blood*; D000255:Adenosine Triphosphate / Q000097:blood*; D001786:Blood Glucose / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism*; D006019:Glycolysis; D006400:Hematocrit; D006801:Humans; D066298:In Vitro Techniques; D007288:Inosine / Q000097:blood; D007700:Kinetics; D007773:Lactates / Q000097:blood; D010710:Phosphates / Q000494:pharmacology
D001786:Blood Glucose; D007773:Lactates; D010710:Phosphates; D007288:Inosine; D000255:Adenosine Triphosphate; D000241:Adenosine